Masonic Medical Research Institute, Utica, New York 13501, United States.
Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States.
ACS Sens. 2021 Jun 25;6(6):2225-2232. doi: 10.1021/acssensors.1c00124. Epub 2021 May 31.
Platelets play a prominent role in multiple diseases, in particular arterial and venous thrombosis and also in atherosclerosis and cancer. To advance the study of the biological activity of this cell type from a basic experimental focus to a clinical focus, new translatable platelet-specific molecular imaging agents are required. Herein, we report the development of a near-infrared fluorescence probe based upon tirofiban, a clinically approved small-molecule glycoprotein IIb/IIIa inhibitor (GPIIb/IIIa). Through experiments with human platelets and ones in a murine model of deep-vein thrombosis, we demonstrate the avidity of the generated probe for activated platelets, with the added benefit of a short blood half-life, thereby enabling rapid visualization within the vasculature.
血小板在多种疾病中起着重要作用,特别是在动脉和静脉血栓形成以及动脉粥样硬化和癌症中。为了将这种细胞类型的生物学活性研究从基础实验焦点推进到临床焦点,需要新的可转化的血小板特异性分子成像剂。在这里,我们报告了基于替罗非班的近红外荧光探针的开发,替罗非班是一种临床批准的小分子糖蛋白 IIb/IIIa 抑制剂(GPIIb/IIIa)。通过对人血小板和深静脉血栓形成的小鼠模型的实验,我们证明了所产生的探针对活化血小板的亲和力,同时具有较短的血液半衰期的优点,从而能够在血管内快速可视化。